SCHEMBL16449302

SCHEMBL16449302

Cc1ccc(C(=O)N[C@H]2CCCCC/C=C\[C@@H]3C[C@@]3(C(=O)NS(=O)(=O)C3CC3)NC(=O)[C@@H]3C[C@@H](Oc4nc5cc(F)ccc5c5cc(F)ccc45)CN3C2=O)o1

nearest known ligand 0.46

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
▸ CTSB P07858 1/20 0.42
▸ ADRB3 P13945 1/20 0.42
▸ ADRA2B P18089 1/20 0.42
▸ ADRA2C P18825 1/20 0.42
▸ CYP3A4 P08684 2/20 0.39
▸ CTSS P25774 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13975776 0.93 CYP3A4 (0.46) CTSBADRB3ADRA2BADRA2CCYP3A4
SCHEMBL16449323 0.93 CTSB (0.42) CTSBADRB3ADRA2BADRA2CCYP3A4
SCHEMBL13975603 0.92 CTSB (0.43) CTSBADRB3ADRA2BADRA2CCYP3A4
SCHEMBL3072606 0.92 CTSB (0.46) CTSBADRB3ADRA2BADRA2CCYP3A4
SCHEMBL3072599 0.92 CTSB (0.46) CTSBADRB3ADRA2BADRA2CCYP3A4
SCHEMBL13975166 0.92 ADRB3 (0.43) CTSBADRB3ADRA2BADRA2CCYP3A4
SCHEMBL16449303 0.91 ADRB3 (0.43) CTSBADRB3ADRA2BADRA2CCYP3A4
SCHEMBL2131945 0.90 CYP3A4 (0.39) CTSBADRB3ADRA2BADRA2CCYP3A4
SCHEMBL2131948 0.90 CYP3A4 (0.39) CTSBADRB3ADRA2BADRA2CCYP3A4
SCHEMBL16449320 0.90 CTSB (0.43) CTSBADRB3ADRA2BADRA2CCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8951964-B2 Phenanthridine macrocyclic hepatitis C serine protease inhibitors ABBVIE INC. (US) 2015-02-10 — — US disclosed
Send feedback